Detalhe da pesquisa
1.
Call to action: Harmonization of pharmacovigilance regulations for post-marketing pregnancy and breastfeeding safety studies.
Br J Clin Pharmacol;
90(3): 715-721, 2024 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37793773
2.
Risk of cardiovascular and cerebrovascular events and mortality in patients with migraine receiving prophylactic treatments: An observational cohort study.
Cephalalgia;
39(12): 1544-1559, 2019 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31195804
3.
Phase 1, randomized, parallel-group, double-blind, placebo-controlled trial to evaluate the effects of erenumab (AMG 334) and concomitant sumatriptan on blood pressure in healthy volunteers.
Cephalalgia;
39(1): 100-110, 2019 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29783863
4.
Pregnancy, Birth, Neonatal, and Postnatal Neurological Outcomes After Pregnancy With Migraine.
Headache;
59(6): 869-879, 2019 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31069791
5.
Regulations Governing Medicines for Maternal and Neonatal Health: A Landscape Assessment.
Ther Innov Regul Sci;
58(2): 242-257, 2024 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38105314
6.
Vascular safety of erenumab for migraine prevention.
Neurology;
94(5): e497-e510, 2020 02 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31852816